4th Quarter - Report — TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC (2010)

Firm

TEVA PHARMACEUTICALS USA, INC.

Client

TEVA PHARMACEUTICALS USA INC

Income

—

Expenses

$620,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT JOHN CLARK	—
ROBERT FALB	—
TERRI STEWART	—

Contacted: Patent & Trademark Office (PTO); SENATE; Health & Human Services, Dept of (HHS); U.S. Customs & Border Protection; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 767 (111th), H.R. 1859 (111th)

Copyright/Patent/Trademark CPT

H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT JOHN CLARK	—
ROBERT FALB	—
TERRI STEWART	—

Contacted: Health & Human Services, Dept of (HHS); U.S. Customs & Border Protection; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Bills named: S. 369 (111th), H.R. 1260 (111th), S. 1315 (111th), S. 515 (111th), H.R. 1706 (111th), S. 610 (111th)

Trade (domestic/foreign) TRD

Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT JOHN CLARK	—
TERRI STEWART	—

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); U.S. Customs & Border Protection

Health Issues HCR

H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	—
ROBERT FALB	—
TERRI STEWART	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); U.S. Customs & Border Protection; U.S. Trade Representative (USTR)

Bills named: S. 3504 (111th), H.R. 5561 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.